| abstract |
The present invention describes an intrauterine system (1) for use in the treatment of dysfunctional uterine bleeding, hypermenstrual dysmenorrhea, dysmenorrhea, endometriosis, uterine fibrosis, menopausal symptoms, osteoporosis, and urogenital atrophy. The system is formed by a frame 16 that forms an interior space 20 for the reception of a viscera 22 of a therapeutically effective dose of a biologically active compound. The frame has an opening structure that allows access to a substantial portion of the exterior surface of the viscera, and the viscera has a velocity control structure 26 that controls the rate of release of the compound in the uterus. One or more retaining elements 6 are provided on the frame for retaining the frame in the womb of a cancer mammal. |